APA (7th ed.) Citation

Huang W, Qian Z, Shi Y, Zhang Z, Hou R, Mei J, . . . Ding J. (2023). PSMC2 is a Novel Prognostic Biomarker and Predicts Immunotherapeutic Responses: From Pancreatic Cancer to Pan-Cancer. Dove Medical Press.

Chicago Style (17th ed.) Citation

Huang W, Qian Z, Shi Y, Zhang Z, Hou R, Mei J, Xu J, and Ding J. PSMC2 Is a Novel Prognostic Biomarker and Predicts Immunotherapeutic Responses: From Pancreatic Cancer to Pan-Cancer. Dove Medical Press, 2023.

MLA (9th ed.) Citation

Huang W, et al. PSMC2 Is a Novel Prognostic Biomarker and Predicts Immunotherapeutic Responses: From Pancreatic Cancer to Pan-Cancer. Dove Medical Press, 2023.